SciClips

SciClips Sciclips provides various open access scientific platform for researchers

Sciclips (www.sciclips.com) is a web-based company that facilitates scientific collaboration and open innovation among scientists and researchers around the world.

11/21/2012

Cancer Biomarker Strategy to Develop Companion Diagnostics for Predicting Prescription Drug Induced Tumors - Analysis using pioglitazone (Actos) and bladder cancer

10/25/2012

Highlights of recent US patents (issued and applications) on protein biomarkers and molecular diagnostics. (Click on titles to view the details) 1. Gene expression biomarker panel for the prognosis...

09/25/2012

Potential Use of Drug Response-Efficacy Biomarkers for Predicting Life-Threatening Disease Causing Side Effects of Therapeutic Drugs

09/25/2012

Highlights of recent US patents (issued and applications) on protein biomarkers and molecular diagnostics. (Click on titles to view the details) 1. Gene expression markers for the diagnosis of Park...

09/25/2012

Strategies for Rational and Personalized Cancer Biomarker Discovery

Sciclips Launches Oncology Biomarker and Companion Diagnostic Pathway Database [Yahoo News]http://news.yahoo.com/sciclip...
01/19/2012

Sciclips Launches Oncology Biomarker and Companion Diagnostic Pathway Database [Yahoo News]
http://news.yahoo.com/sciclips-launches-oncology-biomarker-companion-diagnostic-pathway-database-081457400.html

Sciclips has launched a comprehensive cancer biomarker database with companion diagnostic pathway maps to meet the growing trend of personalized medicine and advancement in cancer biomarker research.Madison, WI (PRWEB) January 06, 2012 Sciclips, a Madison (WI) based company, has announced the launch...

Tonny JohnsonCancer Theranostics - Potential Applications of Cancer Biomarker DatabaseThis blog analyzes the potential a...
01/19/2012

Tonny Johnson
Cancer Theranostics - Potential Applications of Cancer Biomarker Database
This blog analyzes the potential applications of biomarkers in cancer theranostics (Rx/Dx), a diagnostic therapy process that leads to the development of successful personalized medicine strategies in cancer treatment. Please follow this ink to read this blog: http://sciclips.wordpress.com/2012/01/09/cancer-theranostics-potential-applications-of-cancer-biomarker-database/

Availability of a comprehensive cancer biomarker database may opens up scientific and technical opportunities in developing innovative oncologic theranostics (Rx/Dx), a diagnostic therapy process t...

Cell Based Reporter Assays vs. Animal Studies in Drug Discovery- Potential Limitations, Risks and LiabilitiesThis blog c...
01/19/2012

Cell Based Reporter Assays vs. Animal Studies in Drug Discovery- Potential Limitations, Risks and Liabilities

This blog critically analyzes the potential scientific limitations, risks and liabilities of cell based reporter assays, including non-natural protein based reporter assays (e.g. circularly permuted firefly luciferase or GFP based reporter assays) and stem cell based assays, in drug discovery and development. Scientific arguments have been put forward to suggest that current format of cell based reporter assays may not be ideal for replacing animal studies. This blog also analyzes the potential negative impact of patents and intellectual property (IP) rights in fostering innovations in cell based assays. Finally, this blog warrants imposing accountability, tighter regulations and demanding higher standards in cell based assays that are used in drug discovery and development. Please follow this link to read the full blog article: http://sciclips.wordpress.com/2012/01/16/cell-based-reporter-assays-vs-animal-studies-in-drug-discovery-potential-limitations-risks-and-liabilities/

This blog critically analyzes the potential scientific limitations, risks and liabilities of cell based reporter assays, including non-natural protein based reporter assays (e.g. circularly permute...

09/22/2011

Highlights of recent stem cell patents issued on Sept.20, 2011 (US patents) and patent applications published on Sept.15, 2011 (US and WO (PCT)).

1. Marker for determining the susceptibility of a cancer patient to an osteoblastic response in mesenchymal stem cells
2.Treating radiation damage using genetically modified mesenchymal stem cells
3. Anti-apoptotic protein STC-1 expressing stem cells for the treatment of prostate cancer
4. Treating leukemia using PTH/PTHrP receptor antagonists that increase the normal hematopoietic stem cells
5. Method for isolating breast cancer stem cells

Details: http://www.sciclips.com/sciclips/drug-discovery-news.do

Drug discovery news

Address

Madison, WI
53713

Alerts

Be the first to know and let us send you an email when SciClips posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category